Barely Significant
← all excerpts

Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study.

Cardiovasc Diabetol · 2024 · PMC10854175 · PMID 38331780

Europe PMCDOI
1
hedged sentence
0.0600
closest p · 1.2× alpha
0.0600
boldest claim

The sentences

nearly significantP = 0.06so close (0.05 < p ≤ 0.1)
The between-treatment differences were significant for HDL-C ( P = 0.02) and apo B48 ( P = 0.006), and nearly significant for apo A1 ( P = 0.06).

also in 3,279 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.